chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I did not have an adverse reaction to the vaccine but contracted Covid in May. I was Covid positive in January 2021 too. Took Bamlanivimab for Covid in January and I took Bebtelovimab in May. They both worked really well. Scratching throat, the sore throat got worse, I had stuffy nose, nausea, fatigue and body aches in both cases.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Developed rash over body, primarily concentrated in groin and armpits, but distributed throughout body except for face. Tried over the counter benadryl pills and cream with no success.  Got progressively worse over the next 3 days.  Had for four days before going to urgent care.  Other causes (food, new soap, lotions, etc.) were ruled out. Diagnosed as: Systemic acute urticaria of unknown origin Was given benadryl shot and prescription for a 5 day course of prednisone. Was recommended to take anti-histamine in the morning and continue with benadryl cream; Aveeno oatmeal baths, if needed. Was given a referral to dermatology.  One day post doctor's visit, no visible relief of symptoms.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive, Skin disorder
Clinical narrative: 05/15/22022 I developed congestion and seem to a be a postnasal drip. The next morning, I had a mild cough and creepy skin. I took a home COVID test which was negative. Several days later I took a second test, and it was positive. My doctor prescribed Paxlovid. I am on the third day of the Paxlovid, and I still feel a lot better. I only have a little bit of congestion still.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: 05/15/22022 I developed congestion and seem to a be a postnasal drip. The next morning, I had a mild cough and creepy skin. I took a home COVID test which was negative. Several days later I took a second test, and it was positive. My doctor prescribed Paxlovid. I am on the third day of the Paxlovid, and I still feel a lot better. I only have a little bit of congestion still.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fatigue, Feeling abnormal, Nasal congestion, Nasal disorder
Clinical narrative: Exposure date possible: 05/10/2022, and then again  05/12/2022, 05/12/2022 Nasal issues and congestion started to come about. and on the 05/14/2022 I started to get brain fog and began to feel out of it. Never had a fever or other symptoms. I felt tired prior however just normal fatigue that didn't seem abnormal. I did have a COVID-19 Test on Friday 05/13/2022 that was negative, and retested on 05/14/2022 Negative test again. I retested on Tuesday 05/17/2022 with a Positive result. I still have some nasal congestion and I am still testing positive as of 05/20/2022.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Bladder catheterisation, Blood pH decreased, Blood potassium increased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/22/21 (lot NA) Pfizer Dose 2 2/12/21 (lot NA) COVID Positive 12/18/21  12/25/21: This is a 57 yo male patient who presented to the ED today b ecause of COVID infection via ambulance  The patient has underlying intellectual disability ( could not confirm per chart review but I called the brother who reports patient was born with speech impairment)  Patient lives with his mother who recently was in the hospital until yesterday. He currently is not able to provide much history  The patient tested positive for COVID on December 18th. Per his brother he was vaccinnated with 1 shot of vaccine of unknown brand. He has been having a cough that is non productive without associated shortness of breath. He has been feeling weak with decreased activity, decreased appetite  Patient has history of insulin dependent diabetes, hypertension, hyperlipidemia  He underwent blood work in the ER with a negative d-dimer, elevated potassium at 6.4, renal dysfunction with BUN/Cr 2.12, venous pH at 7.19. CXR shows concerns for viral pneumonia. He was given NS boluses and started on D5W sodium bicarbonate drip. He underwent preliminary treatment for hyperkalemia in the ED. Nephrology was consulted by EDP  Patient's blood pressure is borderline in the ED, responsive for IVF. I have asked EDP to further stabilize prior to transferring to the floor  12/28/21: Patient is admitted hospital, kept on contact and droplet precautions, started on empirical IV antibiotics with ceftriaxone doxycycline along with dexamethasone and supportive care.  Pulse ox is monitored.  Patient is noted to have acute urinary retention, indwelling Foley catheter is placed.  On-call urologist Dr is consulted, and he recommended indwelling Foley catheter placement and outpatient follow-up with Urology.  Nephrology consult is requested for acute kidney injury and hyperkalemia, patient is seen and followed by Dr, fluid management is done as per her recommendations, with IV bicarbonate drip. Hyperkalemia has resolved, renal function is normalized. Patient is afebrile, hemodynamically stable, hypoxic as well, saturating well on room air.  He was given given IV remdesivir due to acute kidney injury.  His blood pressures were soft, antihypertensives were held and was started on midodrine.  Patient's blood pressure stable now, metoprolol XL is resumed.  Lisinopril is discontinued due to acute kidney injury and hyperkalemia.  Patient is stable for discharge today.  His lisinopril is discontinued, this needs to be addressed as outpatient.  Is discharged on midodrine 2.5 mg p.o. t.i.d. for 1 week.  Is also discharged on oral prednisone and doxycycline with supportive care.  Also is discharged with indwelling Foley catheter, needs outpatient follow-up with Urology.  He is started on Flomax daily.  He is discharged visiting nurse services.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Blood urea nitrogen/creatinine ratio, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/22/21 (lot NA) Pfizer Dose 2 2/12/21 (lot NA) COVID Positive 12/18/21  12/25/21: This is a 57 yo male patient who presented to the ED today b ecause of COVID infection via ambulance  The patient has underlying intellectual disability ( could not confirm per chart review but I called the brother who reports patient was born with speech impairment)  Patient lives with his mother who recently was in the hospital until yesterday. He currently is not able to provide much history  The patient tested positive for COVID on December 18th. Per his brother he was vaccinnated with 1 shot of vaccine of unknown brand. He has been having a cough that is non productive without associated shortness of breath. He has been feeling weak with decreased activity, decreased appetite  Patient has history of insulin dependent diabetes, hypertension, hyperlipidemia  He underwent blood work in the ER with a negative d-dimer, elevated potassium at 6.4, renal dysfunction with BUN/Cr 2.12, venous pH at 7.19. CXR shows concerns for viral pneumonia. He was given NS boluses and started on D5W sodium bicarbonate drip. He underwent preliminary treatment for hyperkalemia in the ED. Nephrology was consulted by EDP  Patient's blood pressure is borderline in the ED, responsive for IVF. I have asked EDP to further stabilize prior to transferring to the floor  12/28/21: Patient is admitted hospital, kept on contact and droplet precautions, started on empirical IV antibiotics with ceftriaxone doxycycline along with dexamethasone and supportive care.  Pulse ox is monitored.  Patient is noted to have acute urinary retention, indwelling Foley catheter is placed.  On-call urologist Dr is consulted, and he recommended indwelling Foley catheter placement and outpatient follow-up with Urology.  Nephrology consult is requested for acute kidney injury and hyperkalemia, patient is seen and followed by Dr, fluid management is done as per her recommendations, with IV bicarbonate drip. Hyperkalemia has resolved, renal function is normalized. Patient is afebrile, hemodynamically stable, hypoxic as well, saturating well on room air.  He was given given IV remdesivir due to acute kidney injury.  His blood pressures were soft, antihypertensives were held and was started on midodrine.  Patient's blood pressure stable now, metoprolol XL is resumed.  Lisinopril is discontinued due to acute kidney injury and hyperkalemia.  Patient is stable for discharge today.  His lisinopril is discontinued, this needs to be addressed as outpatient.  Is discharged on midodrine 2.5 mg p.o. t.i.d. for 1 week.  Is also discharged on oral prednisone and doxycycline with supportive care.  Also is discharged with indwelling Foley catheter, needs outpatient follow-up with Urology.  He is started on Flomax daily.  He is discharged visiting nurse services.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fibrin D dimer, Hyperkalaemia, Hypoxia, Mobility decreased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/22/21 (lot NA) Pfizer Dose 2 2/12/21 (lot NA) COVID Positive 12/18/21  12/25/21: This is a 57 yo male patient who presented to the ED today b ecause of COVID infection via ambulance  The patient has underlying intellectual disability ( could not confirm per chart review but I called the brother who reports patient was born with speech impairment)  Patient lives with his mother who recently was in the hospital until yesterday. He currently is not able to provide much history  The patient tested positive for COVID on December 18th. Per his brother he was vaccinnated with 1 shot of vaccine of unknown brand. He has been having a cough that is non productive without associated shortness of breath. He has been feeling weak with decreased activity, decreased appetite  Patient has history of insulin dependent diabetes, hypertension, hyperlipidemia  He underwent blood work in the ER with a negative d-dimer, elevated potassium at 6.4, renal dysfunction with BUN/Cr 2.12, venous pH at 7.19. CXR shows concerns for viral pneumonia. He was given NS boluses and started on D5W sodium bicarbonate drip. He underwent preliminary treatment for hyperkalemia in the ED. Nephrology was consulted by EDP  Patient's blood pressure is borderline in the ED, responsive for IVF. I have asked EDP to further stabilize prior to transferring to the floor  12/28/21: Patient is admitted hospital, kept on contact and droplet precautions, started on empirical IV antibiotics with ceftriaxone doxycycline along with dexamethasone and supportive care.  Pulse ox is monitored.  Patient is noted to have acute urinary retention, indwelling Foley catheter is placed.  On-call urologist Dr is consulted, and he recommended indwelling Foley catheter placement and outpatient follow-up with Urology.  Nephrology consult is requested for acute kidney injury and hyperkalemia, patient is seen and followed by Dr, fluid management is done as per her recommendations, with IV bicarbonate drip. Hyperkalemia has resolved, renal function is normalized. Patient is afebrile, hemodynamically stable, hypoxic as well, saturating well on room air.  He was given given IV remdesivir due to acute kidney injury.  His blood pressures were soft, antihypertensives were held and was started on midodrine.  Patient's blood pressure stable now, metoprolol XL is resumed.  Lisinopril is discontinued due to acute kidney injury and hyperkalemia.  Patient is stable for discharge today.  His lisinopril is discontinued, this needs to be addressed as outpatient.  Is discharged on midodrine 2.5 mg p.o. t.i.d. for 1 week.  Is also discharged on oral prednisone and doxycycline with supportive care.  Also is discharged with indwelling Foley catheter, needs outpatient follow-up with Urology.  He is started on Flomax daily.  He is discharged visiting nurse services.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Renal impairment, SARS-CoV-2 test positive, Urinary retention, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/22/21 (lot NA) Pfizer Dose 2 2/12/21 (lot NA) COVID Positive 12/18/21  12/25/21: This is a 57 yo male patient who presented to the ED today b ecause of COVID infection via ambulance  The patient has underlying intellectual disability ( could not confirm per chart review but I called the brother who reports patient was born with speech impairment)  Patient lives with his mother who recently was in the hospital until yesterday. He currently is not able to provide much history  The patient tested positive for COVID on December 18th. Per his brother he was vaccinnated with 1 shot of vaccine of unknown brand. He has been having a cough that is non productive without associated shortness of breath. He has been feeling weak with decreased activity, decreased appetite  Patient has history of insulin dependent diabetes, hypertension, hyperlipidemia  He underwent blood work in the ER with a negative d-dimer, elevated potassium at 6.4, renal dysfunction with BUN/Cr 2.12, venous pH at 7.19. CXR shows concerns for viral pneumonia. He was given NS boluses and started on D5W sodium bicarbonate drip. He underwent preliminary treatment for hyperkalemia in the ED. Nephrology was consulted by EDP  Patient's blood pressure is borderline in the ED, responsive for IVF. I have asked EDP to further stabilize prior to transferring to the floor  12/28/21: Patient is admitted hospital, kept on contact and droplet precautions, started on empirical IV antibiotics with ceftriaxone doxycycline along with dexamethasone and supportive care.  Pulse ox is monitored.  Patient is noted to have acute urinary retention, indwelling Foley catheter is placed.  On-call urologist Dr is consulted, and he recommended indwelling Foley catheter placement and outpatient follow-up with Urology.  Nephrology consult is requested for acute kidney injury and hyperkalemia, patient is seen and followed by Dr, fluid management is done as per her recommendations, with IV bicarbonate drip. Hyperkalemia has resolved, renal function is normalized. Patient is afebrile, hemodynamically stable, hypoxic as well, saturating well on room air.  He was given given IV remdesivir due to acute kidney injury.  His blood pressures were soft, antihypertensives were held and was started on midodrine.  Patient's blood pressure stable now, metoprolol XL is resumed.  Lisinopril is discontinued due to acute kidney injury and hyperkalemia.  Patient is stable for discharge today.  His lisinopril is discontinued, this needs to be addressed as outpatient.  Is discharged on midodrine 2.5 mg p.o. t.i.d. for 1 week.  Is also discharged on oral prednisone and doxycycline with supportive care.  Also is discharged with indwelling Foley catheter, needs outpatient follow-up with Urology.  He is started on Flomax daily.  He is discharged visiting nurse services.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENT RECEIVED MODERNA VACCINE AT 17 YO. MODERNA VACCINE IS APPROVED FOR AGES 18 YO AND ABOVE.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Herpes zoster, Pain, Rash
Clinical narrative: Patient's wife called 5/20/22 morning to report that the patient had developed a 3" patch of rash on his buttocks in addition to groin area that had a "polka dot-like" appearance. She also stated he had "a bad headache and ached all over" on 5/19/22. The patient received a Shingrix immunization on 5/18/22. The patient's wife was wondering if the rash may have been due to the Shingrix shot. I advised patient to have the rash examined by his physician. The patient saw his provider and was told it did in fact look like it could be a shingles rash. The provider prescribed valacyclovir and gabapentin for the patient and advised him he may not want to get the second Shingrix dose.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood culture, Blood glucose increased, Blood lactic acid, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cellulitis, Chest X-ray normal, Fatigue, Haematuria
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperkalaemia, Hyporesponsive to stimuli, Hypotension, Hypoxia, Laboratory test
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Leukocytosis, Limb injury, Memory impairment, Oxygen saturation decreased, Pyrexia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory arrest, SARS-CoV-2 test positive, Seizure, Sepsis, Tremor
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis abnormal, Vaccine breakthrough infection, White blood cell count increased, Wound infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/25/21  12/25/21: Patient is a 93-year-old female with past medical history of CAD, CVD, HFpEF, type 2 diabetes, atrial fibrillation, hypertension, hyperlipidemia, OSA,  GERD, and anxiety.  She presented on 12/25/2021.  There was concern at the nursing home that she had a seizure.  She was therefore transferred to the emergency department.  On arrival, the patient was febrile with temperature of 100.6° F, she was also requiring O2 at 4 liters/minute to maintain adequate saturations.  At baseline, the patient uses O2 at night, but was desatting while laying supine per nursing report.  She was mildly hypotensive as well with 1 blood pressure reading of 94/51, but this did improve with fluid administration.  Chest x-ray negative for acute findings. UA was unremarkable with the exception of microscopic hematuria.  Blood cultures pending.  Lab work notable for glucose 278, lactic acid of 3.2, WBC of 26, UA negative. Patient does have a chronic right lower extremity wound and her apparent sepsis is believed to be secondary to infection of this wound.  She was admitted for further management of this.  History is obtained from chart review and discussion with ED provider.  Patient is tired and slow to respond.  When I asked her how she was doing, she did say "Oh, pretty good."  I asked her if anything was bothering her and she responded "oh, I guess not."   She could not tell me where she was or why she was here.  She did not know what year it was.  I tried asking specific questions on review of systems, but she did not respond. This is reported to be her baseline mentation per nursing report.  Also, floor nurse informed me that she spoke with staff at nursing home who for pretty convinced that patient did in fact have a seizure.  She was reported to be shaking uncontrollably on the ground and not breathing at the nursing home.  12/29/21: Likely sepsis due to right lower extremity cellulitis.  Resolved. New diagnosis of COVID-19 pneumonia, present before current admission to hospital.  Acute hypoxia and O2 requirement down to 1 liter/minute. Baseline she is only on oxygen at night.  T2 dm, worse this morning because of steroid.  Steroid discontinued.  AFib history but not on oral anticoagulation likely because of advanced age.  HTN/HLD/OSA/GERD/anxiety  , stable.  Marked leukocytosis likely due to sepsis.  Improving.  Mild hyperkalemia, resolved.  She remains a DNR
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chemotherapy, Malaise, Metastatic renal cell carcinoma, SARS-CoV-2 test positive
Clinical narrative: Received Moderna vaccines on 2/26/21, 3/26/21, 9/23/21, 2/25/22; positive for COVID by PCR on 5/19/22. Admitted to hospital on 5/19/22 d/t mild/moderate COVID symptoms in pt with metastatic renal cell cancer on chemo.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: AFTER RECEIVING THE VACCINE, PATIENT SAT DOWN FOR 15-MINUTE OBSERVATION PERIOD AND SAID HE EXPERIENCED LIGHTHEADEDNESS. HE SAID HE FELT AS IF HE WAS GOING TO LOSE CONSCIOUSNESS, SO WE CALLED PARAMEDICS, WHO CAME TOOK THE PATIENT TO THE HOSPITAL AFTER TAKING HIS VITALS.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Joint stiffness, Musculoskeletal stiffness
Clinical narrative: Symptoms seem to be similar to Reactive Arthritis: severe joint pain and stiffness (knees, ankles, wrists, lower back)
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Burning sensation, Dyspnoea, Hypoaesthesia, Injection site swelling
Clinical narrative: Within 30 minutes of the vaccine my head and neck started to itch. There were no hives, just itching. This was on and off for 2 days. The day after the vaccine my arm was swollen at injection site and lymph nodes of right arm were swollen and painful. 2 days ofter the vaccine I began having a pins and needles feeling in feet/legs. Mainly the left leg from knee down. This progressed over the next 10 days spreading to my hands and arms. 4 days after the vaccine my left leg from the knee down felt like a muscular issue was happening because it appears partially numb. My limbs repeatedly go numb while sleeping which has never been an issue until after the vaccine. I've had a burning sensation in different parts of my body that come and go including my head, neck and arms. I am having vision changes that go from eye to eye depending on the day. 8 days after the vaccine I had a reaction of hives on my neck (which I've never had before) and some breathing issues. 14 days after the vaccine this reaction happened again. It went away within 2 hours without medication. All of these symptoms are post vaccine and issues that I've never had before getting the vaccine. I am now 15 days post vaccine and have been to the ER twice. I've had an MRI scan on my brain and nothing other than a sinus infection was found. Blood tests were standard.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Magnetic resonance imaging head abnormal, Paraesthesia, Pruritus
Clinical narrative: Within 30 minutes of the vaccine my head and neck started to itch. There were no hives, just itching. This was on and off for 2 days. The day after the vaccine my arm was swollen at injection site and lymph nodes of right arm were swollen and painful. 2 days ofter the vaccine I began having a pins and needles feeling in feet/legs. Mainly the left leg from knee down. This progressed over the next 10 days spreading to my hands and arms. 4 days after the vaccine my left leg from the knee down felt like a muscular issue was happening because it appears partially numb. My limbs repeatedly go numb while sleeping which has never been an issue until after the vaccine. I've had a burning sensation in different parts of my body that come and go including my head, neck and arms. I am having vision changes that go from eye to eye depending on the day. 8 days after the vaccine I had a reaction of hives on my neck (which I've never had before) and some breathing issues. 14 days after the vaccine this reaction happened again. It went away within 2 hours without medication. All of these symptoms are post vaccine and issues that I've never had before getting the vaccine. I am now 15 days post vaccine and have been to the ER twice. I've had an MRI scan on my brain and nothing other than a sinus infection was found. Blood tests were standard.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Urticaria, Visual impairment
Clinical narrative: Within 30 minutes of the vaccine my head and neck started to itch. There were no hives, just itching. This was on and off for 2 days. The day after the vaccine my arm was swollen at injection site and lymph nodes of right arm were swollen and painful. 2 days ofter the vaccine I began having a pins and needles feeling in feet/legs. Mainly the left leg from knee down. This progressed over the next 10 days spreading to my hands and arms. 4 days after the vaccine my left leg from the knee down felt like a muscular issue was happening because it appears partially numb. My limbs repeatedly go numb while sleeping which has never been an issue until after the vaccine. I've had a burning sensation in different parts of my body that come and go including my head, neck and arms. I am having vision changes that go from eye to eye depending on the day. 8 days after the vaccine I had a reaction of hives on my neck (which I've never had before) and some breathing issues. 14 days after the vaccine this reaction happened again. It went away within 2 hours without medication. All of these symptoms are post vaccine and issues that I've never had before getting the vaccine. I am now 15 days post vaccine and have been to the ER twice. I've had an MRI scan on my brain and nothing other than a sinus infection was found. Blood tests were standard.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I test positive for COVID 40 days after 4th vaccine of Johnson & Johnson.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: none
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Erythema, Injected limb mobility decreased, Joint range of motion decreased, Muscular weakness
Clinical narrative: About 5 hours after receiving the vaccine my arm swelled up, turned red, was hot to the touch, very painful and itched. I took some advil with no relief.  The next day the pain radiated from my elbow up to my neck area.  As days progressed the pain continued and my arm was feeling weaker. My husband had the shot the year before and told me it was a rough one and the pain would go away.  Painin my arm, neck, shoulder and rear shoulder blade is a daily pain.  My arm has become weaker and my range of motion became less and less.  Sleeping on my left side is almost impossible. Raising my left arm outward away from my body has decreased by about 70%.  Daily life has been impacted.  I finally contacted my doctor when I re
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal pain, Neck pain, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: About 5 hours after receiving the vaccine my arm swelled up, turned red, was hot to the touch, very painful and itched. I took some advil with no relief.  The next day the pain radiated from my elbow up to my neck area.  As days progressed the pain continued and my arm was feeling weaker. My husband had the shot the year before and told me it was a rough one and the pain would go away.  Painin my arm, neck, shoulder and rear shoulder blade is a daily pain.  My arm has become weaker and my range of motion became less and less.  Sleeping on my left side is almost impossible. Raising my left arm outward away from my body has decreased by about 70%.  Daily life has been impacted.  I finally contacted my doctor when I re
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Skin warm, Sleep disorder
Clinical narrative: About 5 hours after receiving the vaccine my arm swelled up, turned red, was hot to the touch, very painful and itched. I took some advil with no relief.  The next day the pain radiated from my elbow up to my neck area.  As days progressed the pain continued and my arm was feeling weaker. My husband had the shot the year before and told me it was a rough one and the pain would go away.  Painin my arm, neck, shoulder and rear shoulder blade is a daily pain.  My arm has become weaker and my range of motion became less and less.  Sleeping on my left side is almost impossible. Raising my left arm outward away from my body has decreased by about 70%.  Daily life has been impacted.  I finally contacted my doctor when I re
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Heart rate increased, Hypertension, Ventricular extrasystoles
Clinical narrative: I received my 2nd booster shot on 04/22/2022 and on the same day I experienced that my heart beat was really fast, my blood pressure was very high, that I almost called 911 and PVC wasn't normal. My blood pressure stayed for 22 weeks. My heart rate was high for 3 weeks and my heart rate is 55-57 which is normal and it was 70-80. On May 13/2022, it finally settled down. I called my doctor I told her that I was taking extra on my blood pressure med and she said it was ok to do that and it stated coming down. At night, my PVC was high so I was taking vallum to lowered it down. I did EKG before I got my booster shot and it was ok but after the vaccine everything went out.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Oropharyngeal pain
Clinical narrative: I contracted COVID-19 on 05/16/2022 with sore throat, cough, a mild fever, and  fatigue. I did a COVID-19 rapid nasal swab that was negative on 05/16/2022, and after my daughter tested positive I also had another COVID-19 rapid nasal swab that was positive on 05/18/2022. I began to feel better on 05/18/2022 after I was prescribed Paxlovid the morning I tested positive. My symptoms have resolved as of today 05/20/2022, with no lingering symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I contracted COVID-19 on 05/16/2022 with sore throat, cough, a mild fever, and  fatigue. I did a COVID-19 rapid nasal swab that was negative on 05/16/2022, and after my daughter tested positive I also had another COVID-19 rapid nasal swab that was positive on 05/18/2022. I began to feel better on 05/18/2022 after I was prescribed Paxlovid the morning I tested positive. My symptoms have resolved as of today 05/20/2022, with no lingering symptoms.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: NO ADVERSE REACTYIKON WHATSOEVER!!  Exp date of vaccine was 03/19/2022
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.